Congress Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.72M Buy
21,845
+1,033
+5% +$131K 0.03% 507
2025
Q1
$2.65M Buy
20,812
+4,977
+31% +$766K 0.03% 439
2024
Q4
$2.28M Sell
15,835
-898
-5% -$129K 0.03% 392
2024
Q3
$2.49M Buy
16,733
+2,058
+14% +$295K 0.03% 387
2024
Q2
$1.85M Buy
14,675
+1,455
+11% +$228K 0.03% 371
2024
Q1
$2.43M Buy
13,220
+1,362
+11% +$259K 0.04% 293
2023
Q4
$2.13M Buy
11,858
+1,113
+10% +$173K 0.04% 305
2023
Q3
$1.71M Buy
10,745
+1,070
+11% +$175K 0.04% 317
2023
Q2
$1.37M Buy
9,675
+456
+5% +$73.1K 0.03% 311
2023
Q1
$1.55M Buy
9,219
+1,544
+20% +$275K 0.04% 297
2022
Q4
$1.3M Buy
7,675
+633
+9% +$115K 0.03% 311
2022
Q3
$1.32M Buy
7,042
+1,185
+20% +$250K 0.04% 305
2022
Q2
$950K Sell
5,857
-36,418
-86% -$5.76M 0.02% 338
2022
Q1
$7.95M Buy
42,275
+13,687
+48% +$2.6M 0.17% 167
2021
Q4
$7.57M Buy
+28,588
New +$7.7M 0.15% 181

Other funds holding RGEN

Congress Wealth Management's RGEN Position: Q2 2025 in Review

Congress Wealth Management increased its Repligen (RGEN) stake by 5% in Q2 2025, buying an estimated $131K and bringing the position to 21,845 shares worth $2.72M. The position accounts for 0.03% of the portfolio, ranked #507.

Congress Wealth Management first reported a position in RGEN in Q4 2021 and has held it in 15 quarters since. The position peaked at $7.95M in Q1 2022. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Congress Wealth Management held 21,845 shares of Repligen worth $2.72M as of Q2 2025.
  • Congress Wealth Management bought 1,033 Repligen shares in Q2 2025, an estimated $131K.
  • Repligen made up 0.03% of Congress Wealth Management's portfolio in Q2 2025, its #507 holding.
  • Congress Wealth Management first reported a position in Repligen in Q4 2021 and has held it in 15 quarters since.
  • Congress Wealth Management's Repligen position peaked at $7.95M in Q1 2022.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.